BD blog

By Kalvin Yu and Diane Flayhart As we recognize World AMR Awareness Week, we reflect on how the globe has recognized and reacted to public health crises and how these crises have impacted...

Blood collection is a vital procedure in clinical diagnostics and research, as it provides valuable information about the health status and biomarkers of patients and participants. However, blood...

One of the most prominent issues today for pharmacies is staff burnout. This trend was accelerated by the COVID-19 pandemic, as pharmacists were being asked to do more and respond to critical...

By Kalvin Yu, MD, FIDSA, Vice President of Medical Affairs for North America Clinical studies have reported that hospital onset bacteremia (HOB) and false-positive blood cultures can have...

Both companies are working to help reduce environmental impact of the BD syringe portfolio in health care facilities By Chee Lum, vice president and general manager of Injection Systems at BD Over...

For more than a decade, BD, PEPFAR and the CDC worked to help strengthen laboratory systems and fight HIV and TB in sub-Saharan Africa and India through the Labs for Life partnership. The Labs for...

By Kalvin Yu, MD, FIDSA, Vice President of U.S. Medical Affairs and Vikas Gupta, Pharm.D., Director of Medical Affairs In our ninth weekly snapshot of viral infections across the U.S, we present...

By Kalvin Yu, MD, FIDSA, Vice President of U.S. Medical Affairs and Vikas Gupta, Pharm.D., Director of Medical Affairs In our eighth weekly snapshot of viral infections across the U.S, we present...

By Kalvin Yu, MD, FIDSA, Vice President of U.S. Medical Affairs and Vikas Gupta, Pharm.D., Director of Medical Affairs In our seventh weekly snapshot of viral infections across the U.S, we present...

By Kalvin Yu, MD, FIDSA, Vice President of U.S. Medical Affairs and Vikas Gupta, Pharm.D., Director of Medical Affairs In our sixth weekly snapshot of viral infections across the U.S, we present...